Sartorius Stedim Biotech adds PESU membranes to benchtop filtration techs
Sartorius Stedim Biotech (SSB) claims benchtop vaccine and protein purification techs could save developers €2000 per batch and reduce processing time by 60%.
Archives for October 3, 2016
Samsung Bioepis Herceptin biosimilar accepted for review in EU
The EMA will assess a version of Roche’s breast cancer drug Herceptin (trastuzumab), the fifth biosimilar candidate submitted for review by Samsung Bioepis.